CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 16 enrolled
Drug / intervention
High Flow Nasal Cannuladevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00356668
NCT00356668Phase 3Completed
CompareCT.gov

Observational, Cross-over Study of the Positive Distending Pressure Generated by Humidified High Flow Nasal Cannula as Compared to Nasal Continuous Positive Airway Pressure

Children's Hospitals and Clinics of Minnesota·interventional·Posted Jul 26, 2006·Updated Jul 14, 2015

In Brief

A Phase 3 clinical trial evaluating High Flow Nasal Cannula for Respiratory Distress Syndrome and Cronic Lung Disease. Completed, enrolled 16 participants across 1 site.

Detailed Summary

The specific aims of this study are to evaluate the amount of high flow nasal cannula (HFNC) gas flow required to generate an equivalent positive distending pressure as that provided by nasal continuous positive airway pressure (NCPAP) of 6 cm H2O, assess the relationships between positive distending pressure, gas flow, oxygen requirement, and patient weight, and lastly, develop an appropriate protocol to be used in the NICU for transitioning patients from NCPAP to an equivalent amount of HFNC.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRespiratory Distress Syndrome, Cronic Lung Disease
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 26, 2006
Enrollment StartJul 1, 2006
Study CompletionSep 1, 2007
TodayJul 2, 2026
Posted 19.9 years ago

Interventions

High Flow Nasal Cannuladevice

30 minute blocks on varying flows of high flow nasal cannula